Central Retinal Vein Occlusion: Clinical Trials

7 trials for Central Retinal Vein Occlusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 not yet recruiting, 1 terminated, 1 unknown. 7 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 47Completed 4, Not yet recruiting 1, Terminated 1, Unknown 1

Follow Central Retinal Vein Occlusion: new trials by email Literature Review of Central Retinal Vein Occlusion trials Research Report on Central Retinal Vein Occlusion

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Emerging Indications for Hyperbaric Oxygen Treatment
Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis
Phase 4Not yet recruitingJay C. Buckey Jr.1002026-11-012026-09-09
Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO
Aflibercept (Eylea, BAY86-5321) - Central Retinal Vein Occlusion
Phase 4CompletedBayer1622016-06-102020-07-08
Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO
Aflibercept - Retinal Vein Occlusion, Diabetic Macular Edema
Phase 4CompletedJustis Ehlers312015-08-182021-05-12
Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen
Aflibercept, Ranibizumab - Central Retinal Vein Occlusion
Phase 4CompletedAnders Kvanta402014-10-012020-12-04
Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion
Ozurdex, Ranibizumab, Combination Ozurdex with Ranibizumab PRN - Macular Edema, Central Retinal Vein Occlusion
Phase 4UnknownValley Retina Institute452013-05-012015-12-14
Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion
ranibizumab, hemodilution - Central Retinal Vein Occlusion
Phase 4CompletedCentre Hospitalier Intercommunal Creteil452010-01-012014-08-13
Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO
bevacizumab and triamcinolone - Macular Edema, Central Retinal Vein Occlusion
Phase 4TerminatedAsociación para Evitar la Ceguera en México102007-06-012024-05-30

Narrower conditions

Retinal Vein Occlusion (7)  ·  Macular Edema (3)  ·  Calciphylaxis (1)  ·  Colitis, Ulcerative (1)  ·  Craniocerebral Trauma (1)  ·  Crohn Disease (1)  ·  Enterocolitis, Pseudomembranous (1)  ·  Epidermolysis Bullosa (1)  ·  Frostbite (1)  ·  Graft vs Host Disease (1)  ·  Hypospadias (1)  ·  Invasive Fungal Infections (1)  ·  Multiple Sclerosis (1)  ·  Myositis, Inclusion Body (1)  ·  Optic Neuropathy, Ischemic (1)

Broader conditions

Cardiovascular Diseases (7)  ·  Embolism and Thrombosis (7)  ·  Eye Diseases (7)  ·  Retinal Diseases (7)  ·  Thrombosis (7)  ·  Vascular Diseases (7)  ·  Venous Thrombosis (7)  ·  Macular Degeneration (3)  ·  Retinal Degeneration (3)  ·  Arterial Occlusive Diseases (1)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Bone Diseases (1)

Interventions

Ranibizumab (3)  ·  aflibercept (3)  ·  Bevacizumab (1)  ·  Calcium Dobesilate (1)  ·  Dexamethasone (1)  ·  Hemodilution (1)  ·  Oxygen (1)  ·  Triamcinolone (1)

Sponsors

Anders Kvanta (1)  ·  Asociación para Evitar la Ceguera en México (1)  ·  Bayer (1)  ·  Centre Hospitalier Intercommunal Creteil (1)  ·  Jay C. Buckey Jr. (1)  ·  Justis Ehlers (1)  ·  Valley Retina Institute (1)

Countries

France (2)  ·  United States (2)  ·  Australia (1)  ·  Canada (1)  ·  Denmark (1)  ·  Germany (1)  ·  Italy (1)  ·  Mexico (1)  ·  Spain (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Carmen Gonzalez-Mijares, Physician (1)  ·  Hugo Quiroz-Mercado, Retinologyst (1)  ·  Jay Buckey (1)  ·  Juan Manuel Jimenez Sierra, Retinologyst (1)  ·  Justis P Ehlers, MD (1)  ·  MA Martinez-Castellanos, Physician (1)  ·  Octavio Burgos Vejar, Physician (1)  ·  Omar Honerlager, preresident (1)  ·  Raul Velez-Montoya, Physician (1)  ·  Sofie Westman (1)

Results publications

PMID 27409478, PMID 31757691, PMID 33556381

NIH funding

2009 (1), 2014 (1)